Læknablaðið - 01.11.2015, Blaðsíða 16

Heimildir
1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha
MJ, Cushman M, et al. Heart disease and stroke
statistics—2015 update: a report from the American Heart
Association. Circulation 2015; 131: e29-e322.
2. WHO | The Atlas of Heart Disease and Stroke. WHO
at who.int/cardiovascular_diseases/resources/atlas/en/ -
ágúst 2015.
3. Guðbjartsson T, Andersen K, Danielsen R, Geirsson
A. Yfirlitsgrein um kransæðasjúkdóm - fyrri hluti:
Faraldsfræði, meingerð, einkenni og rannsóknir til grein-
ingar. Læknablaðið 2013; 100: 667-76.
4. Guðbjartsson T, Andersen K, Danielsen R, Geirsson
A. Yfirlitsgrein um kransæðasjúkdóm - síðari hluti:
Lyfjameðferð, kransæðavíkkun og kransæðahjáveituað-
gerð. Læknablaðið 2014; 101: 25-35.
5. Anderson LJ, Taylor RS. Cardiac rehabilitation for people
with heart disease: An overview of Cochrane systematic
reviews. Int J Cardiol 2014; 177: 348-61.
6. Gielen S, Laughlin MH, O’Conner C, Duncker DJ. Exercise
training in patients with heart disease: review of beneficial
effects and clinical recommendations. Prog Cardiovasc
Dis 2015; 57: 347-55.
7. Menezes AR, Lavie CJ, Forman DE, Arena R, Milani RV,
Franklin BA. Cardiac rehabilitation in the elderly. Prog
Cardiovasc Dis 2014; 57: 152-9.
8. Ámundadóttir ÓR. Samanburður á tveimur aðferðum við
endurhæfingu á hjartasjúklingum. [M.S. ritgerð] - Hirsla
- Landspítali. hirsla.lsh.is/lsh/handle/2336/55333 - ágúst
2015.
9. Wenger NK. Current status of cardiac rehabilitation. J Am
Coll Cardiol 2008; 51: 1619-31.
10. Williams MA, Ades PA, Hamm LF, Keteyian SJ,
LaFontaine TP, Roitman JL, et al. Clinical evidence for a
health benefit from cardiac rehabilitation: An update. Am
Heart J 2006; 152: 835-41.
11. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H,
Rees K, et al. Exercise-based rehabilitation for patients
with coronary heart disease: systematic review and meta-
analysis of randomized controlled trials. Am J Med 2004;
116: 682-92.
12. Cardiac rehabilitation programs. A statement for healt-
hcare professionals from the American Heart Association.
Circulation 1994; 90: 1602-10.
13. Kristjánsdóttir Á, Ingvarsdóttir I. Endurhæfing eftir
hjartaaðgerð. 2001. hjartaheill.is/images/stories/annad/
endurh_e_hjartaadg.pdf - ágúst 2015.
14. Bjarnason-Wehrens B, McGee H, Zwisler AD, Piepoli
MF, Benzer W, Schmid JP, et al. Cardiac rehabilitation in
Europe: results from the European Cardiac Rehabilitation
Inventory Survey. Eur J Cardiovasc Prev Rehabil 2010; 17:
410-8.
15. Fletcher GF1, Ades PA, Kligfield P, Arena R, Balady GJ,
Bittner VA, et al. Exercise Standards for Testing and
Training A Scientific Statement From the American Heart
Association. Circulation 2013; 128: 873-934.
16. Balady GJ, Ades PA, Bittner VA, Franklin BA, Gordon NF,
Thomas RJ, et al. Referral, Enrollment, and Delivery of
Cardiac Rehabilitation/Secondary Prevention Programs
at Clinical Centers and Beyond A Presidential Advisory
From the American Heart Association. Circulation 2011;
124: 2951-60.
17. Borg G. Psychophysical scaling with applications in
physical work and the perception of exertion. Scand J
Work Environ Health 1990; 16 Suppl 1: 55-8.
18. Ware J, Kosinski M, Keller S. SF-36 physical and mental
health summary scales: a user’s manual. 1994.
19. AACVPR Risk Stratification Algorithm for Risk of Event.
https://www.aacvpr.org/Portals/0/Registry/AACVPR%20
Risk%20Stratification%20Algorithm_June2012.pdf - ágúst
2015.
20. Aspelund T, Gudnason V, Magnusdottir BT, Andersen
K, Sigurdsson G, Thorsson B, et al. Analysing the large
decline in coronary heart disease mortality in the Icelandic
population aged 25-74 between the years 1981 and 2006.
PLoS ONE 2010; 5: e13957.
21. Embætti landlæknis. Áherslur til heilsueflingar - Ný
skýrsla. landlaeknir.is/um-embaettid/frettir/frett/item
16800 - ágúst 2015.
22. Pandey A, Parashar A, Kumbhani DJ, Agarwal S, Garg J,
Kitzman D, et al. Exercise training in patients with heart
failure and preserved ejection fraction meta-analysis of
randomized control trials. Circ Heart Fail 2015; 8: 33-40.
23. Jónsdóttir S, Andersen KK, Sigurðsson AF, Sigurðsson SB.
The effect of physical training in chronic heart failure. Eur
J Heart Fail 2006; 8: 97-101.
24. Soleimani A, Salarifar M, Kasaian SE, Sadeghian S,
Nejatian M, Abbasi A. Effect of completion of cardiac
rehabilitation on heart rate recovery. Asian Cardiovasc
Thorac Ann 2008; 16: 202-7.
25. Hammill BG, Curtis LH, Schulman KA, Whellan DJ.
Relationship between cardiac rehabilitation and long-
term risks of mortality and myocardial infarction among
elderly medicare beneficiaries. Circulation 2010; 121:
63-70.
26. ter Hoeve N, Huisstede BM, Stam HJ, van Domburg
RT, Sunamura M, van den Berg-Emons RJ. Does cardiac
rehabilitation after an acute cardiac syndrome lead to
changes in physical activity habits? Systematic review.
Phys Ther 2015; 95: 167-79.
27. Lavie CJ, Milani RV. Disparate effects of improving
aerobic exercise capacity and quality of life after cardiac
rehabilitatin in young and elderly coronary patients. J
Cardiopulm Rehabil 2000; 4: 235-40.
28. Linden W, Stossel C, Maurice J. Psychosocial interventions
for patients with coronary artery disease. A Meta-analysis.
Arch Intern Med 1996; 156: 745-52.
29. Lavie CJ, Milani RV. Effects of cardiac rehabilitation,
exercise training, and weight reduction on exercise
capacity, coronary risk factors, behavioral characteristics,
and quality of life in obese coronary patients. Am J Cardiol
1997; 79: 397-401.
30. Ades PA, Waldmann ML, Polk DM, Coflesky JT. Referral
patterns and exercise response in the rehabilitation of
female coronary patients aged ≥62 years. Am J Cardiol
1992; 69: 1422-5.
31. Halm M, Penque S, Doll N, Beahrs M. Women and
cardiac rehabilitation: referral and compliance patterns. J
Cardiovasc Nurs 1999; 13: 83-92.
32. van Lennep JER, Westerveld HT, Erkelens DW, van der
Wall EE. Risk factors for coronary heart disease: implica-
tions of gender. Cardiovasc Res 2002; 53: 538-49.
33. Lerner DJ, Kannel WB. Patterns of coronary heart disease
morbidity and mortality in the sexes: A 26-year follow-up
of the Framingham population. Am Heart J 1986; 111: 383-
90.
ENgLISH SUMMArY
introduction: Cardiac rehabilitation is a well-established treatment for
patients with coronary artery disease but limited information is available
for Icelandic patients. The aim of this study was to investigate whether
Phase II cardiac rehabilitation at the HL rehabilitation center was impro-
ving physical health and quality of life of patients.
Material and methods: Patients that had undergone coronary artery
intervention were invited to participate. There were 64 participants (of 65
invited) that started in the study and 48 that finished. on average parti-
cipants attended 2.1 sessions pr. week, for 8.4 weeks. Measurements
performed: endurance (W/kg), blood pressure and pulse responses from
an exercise test and body mass index (kg/m2). To measure health related
quality of life the SF-36v2 questionnaire was used.
Results: Endurance improved by 14.4% (p<0,001) and a 6.1% increase
was seen in peak pulse (p=0.001). The group was divided by age (32-64
years and 65-86 years) and both age groups improved their endurance
number similarly (14.6% and 14.1%) but only the older age group impro-
ved peak pulse significantly or 7.2% (p=0.007). When the group was
divided according to number of training sessions per week there was a
10.1% increase in endurance in the group that had fewer sessions but it
was 19.8% in those that attended more sessions (p<0.001). Participants
assessed that their physical health, measured with a questionnaire, had
improved at the end of training (p=0.003). When the group was divided
into two groups according to how they measured their physical health at
the beginning of the study there was a significant increase of 15.1% in
physical health in those that estimated worse quality of life at the beg-
inning of the study, but the other group had an increase of 1.2%.
Conclusion: Cardiac rehabilitation improves endurance and physical
wellbeing in patients. Training magnitude is essential for improvement.
Effect of cardiac rehabilitation following coronary bypass surgery or other coronary interventions
Fríða dröfn Ammendrup1, Mundína Ásdís kristinsdóttir2, Gunnar Guðmundsson2,3, Erlingur jóhannsson1
1Research Centre for Sport and Health Sciences, School of Education, University of Iceland2, Reykjavik, Heart and Lung Rehabilitation Center, 3Faculty of Medicine, University of Iceland
key words: cardiac rehabilitation, coronary artery heart disease, coronary artery bypass grafting, percutaneus coronary artery intervention.
Correspondence: Erlingur jóhannsson, erljo@hi.is
R A N N S Ó K N
516 LÆKNAblaðið 2015/101

Spiriva® Respimat® (tíótrópíum) og
Spiriva Respimat

(tíótrópíum)
Striverdi Respimat
(olodaterol)
Nýtt!

Nú fæ
st LA
BA

í Res
pima
t

Striverdi Respimat (olodaterol) er
langverkandi β2-örvi (LABA) í Respimat
Einu sinni á dag
– sem Spiriva Respimat (tíótrópíum)
Respimat innöndunartæki
– sem Spiriva Respimat (tíótrópíum)
Skammtur 5 μg (tvær úðanir, hvor um sig 2,5 μg)
– sem Spiriva Respimat (tíótrópíum)
Striverdi® Respimat (olodaterol)
TILVALIÐ SAMAN
IS
S
tr
-1
4-
01
-0
4
fe
b.
2
01
4
Ábending: Tíótrópíum er ætlað sem berkjuvíkkandi viðhaldsmeðferð
til að lina einkenni hjá sjúklingum með langvinna lungnateppu (LLT).
Ábending: Striverdi Respimat er ætlað sem berkjuvíkkandi
viðhaldsmeðferð hjá sjúklingum með langvinna lungnateppu (LLT).
®